Akinori Maeda

802 total citations
48 papers, 539 citations indexed

About

Akinori Maeda is a scholar working on Surgery, Nephrology and Immunology. According to data from OpenAlex, Akinori Maeda has authored 48 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 12 papers in Nephrology and 10 papers in Immunology. Recurrent topics in Akinori Maeda's work include Acute Kidney Injury Research (8 papers), Hemodynamic Monitoring and Therapy (8 papers) and Dialysis and Renal Disease Management (5 papers). Akinori Maeda is often cited by papers focused on Acute Kidney Injury Research (8 papers), Hemodynamic Monitoring and Therapy (8 papers) and Dialysis and Renal Disease Management (5 papers). Akinori Maeda collaborates with scholars based in Japan, Australia and Italy. Akinori Maeda's co-authors include Masataka Sasada, Kokichi Yamamoto, Masaharu Nohgawa, Nari Harakawa, Kuniko Takano, Minoru Okuma, Kazuo Suzuki, Atsushi Takahashi, Naofumi Mukaida and Kouji Matsushima and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Critical Care Medicine.

In The Last Decade

Akinori Maeda

41 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akinori Maeda Japan 11 178 105 93 82 77 48 539
Takakuni Tanizawa Japan 12 131 0.7× 56 0.5× 73 0.8× 187 2.3× 158 2.1× 44 600
Yutaka Furumitsu Japan 11 130 0.7× 74 0.7× 41 0.4× 43 0.5× 124 1.6× 18 596
Georg Stummvoll Austria 17 544 3.1× 117 1.1× 85 0.9× 45 0.5× 131 1.7× 32 944
Е Н Александрова Russia 11 161 0.9× 60 0.6× 45 0.5× 36 0.4× 90 1.2× 210 610
Markus Zeisbrich Germany 12 289 1.6× 77 0.7× 60 0.6× 39 0.5× 150 1.9× 16 663
Wei‐Cheng Tseng Taiwan 15 107 0.6× 86 0.8× 123 1.3× 148 1.8× 170 2.2× 30 808
Kathrin Schmidbauer Germany 12 213 1.2× 50 0.5× 104 1.1× 139 1.7× 134 1.7× 15 636
Christopher Collins United States 14 495 2.8× 61 0.6× 41 0.4× 74 0.9× 69 0.9× 25 930
Yongen Chang United States 9 60 0.3× 62 0.6× 55 0.6× 84 1.0× 152 2.0× 16 490
Zane Kaplan Australia 11 140 0.8× 117 1.1× 77 0.8× 27 0.3× 83 1.1× 28 692

Countries citing papers authored by Akinori Maeda

Since Specialization
Citations

This map shows the geographic impact of Akinori Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akinori Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akinori Maeda more than expected).

Fields of papers citing papers by Akinori Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akinori Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akinori Maeda. The network helps show where Akinori Maeda may publish in the future.

Co-authorship network of co-authors of Akinori Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Akinori Maeda. A scholar is included among the top collaborators of Akinori Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akinori Maeda. Akinori Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neto, Ary Serpa, et al.. (2025). A target trial emulation of dexmedetomidine to treat agitation in the intensive care unit. PubMed. 37. e20250010–e20250010.
2.
Shimada, Yoshihisa, Yue Cong, Masaaki Nagano, et al.. (2025). Early major adverse kidney events after lung transplantation: risk of chronic kidney disease and prognostic impact. General Thoracic and Cardiovascular Surgery. 74(2). 203–210.
3.
4.
Maeda, Akinori, et al.. (2024). Severe intensive care unit–acquired hypernatraemia: Prevalence, risk factors, trajectory, management, and outcome. Critical Care and Resuscitation. 26(4). 311–318. 2 indexed citations
5.
Maeda, Akinori, Graham Starkey, Glenn M. Eastwood, et al.. (2024). Perfusate hemoglobin during normothermic liver machine perfusion as biomarker of early allograft dysfunction: A pilot study. Artificial Organs. 49(1). 108–118.
6.
Bellomo, Rinaldo, Kyle White, Akinori Maeda, et al.. (2024). Correspondence regarding the article by Murugan et al. on “Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach”. Intensive Care Medicine Experimental. 12(1). 18–18. 1 indexed citations
7.
See, Emily, Akinori Maeda, Caroline Clapham, et al.. (2024). Renin Levels and Angiotensin II Responsiveness in Vasopressor-Dependent Hypotension*. Critical Care Medicine. 52(8). 1218–1227. 7 indexed citations
8.
Maeda, Akinori, Ryota Inokuchi, Rinaldo Bellomo, & Kent Doi. (2024). Heterogeneity in the definition of major adverse kidney events: a scoping review. Intensive Care Medicine. 50(7). 1049–1063. 6 indexed citations
9.
10.
Maeda, Akinori, et al.. (2024). A comparison of anti-coagulation monitoring tests in ICU patients receiving a continuous infusion of unfractionated heparin. Critical Care and Resuscitation. 26(4). 255–261. 2 indexed citations
11.
Maeda, Akinori, et al.. (2024). Efficacy and safety of guanfacine in hospitalized patients with delirium: A scoping review. Critical Care and Resuscitation. 26(4). 286–294. 1 indexed citations
12.
Baldwin, Ian, Akinori Maeda, Rinaldo Bellomo, & Emily See. (2024). Haematocrit monitoring and blood volume estimation during continuous renal replacement therapy. Australian Critical Care. 37(4). 632–637. 3 indexed citations
13.
See, Emily, et al.. (2023). Exploring the orepinephrine to ngiotensin II onversion atio in atients with asodilatory ypotension: A ost-oc nalysis of the ARAMIS rial. Journal of Critical Care. 79. 154453–154453. 2 indexed citations
14.
Mårtensson, Johan, Salvatore Lucio Cutuli, E Osawa, et al.. (2023). Sodium glucose co-transporter-2 inhibitors in intensive care unit patients with type 2 diabetes: a pilot case control study. Critical Care. 27(1). 189–189. 9 indexed citations
15.
Maeda, Akinori, et al.. (2023). Cardiac Output Changes during Renal Replacement Therapy: A Scoping Review. Blood Purification. 53(3). 151–161. 2 indexed citations
16.
Maeda, Akinori, et al.. (2020). Acute Kidney Injury Induces Innate Immune Response and Neutrophil Activation in the Lung. Frontiers in Medicine. 7. 565010–565010. 9 indexed citations
17.
Tanaka, Yasuhiro, Kenichi Nagai, Naoko Watanabe, et al.. (2005). [Renal insufficiency caused by leukemic cell infiltration in Sézary syndrome].. PubMed. 46(5). 368–71. 1 indexed citations
18.
Shima, Norihiro, et al.. (2005). Delayed Latency of Peroneal Reflex to Sudden Inversion with Ankle Taping or Bracing. International Journal of Sports Medicine. 26(6). 476–480. 25 indexed citations
19.
Yanai, Machi, Akinori Maeda, Naoko Watanabe, et al.. (2004). Successful Treatment of µ-Heavy Chain Disease with Fludarabine Monophosphate: A Case Report. International Journal of Hematology. 79(2). 174–177. 6 indexed citations
20.
Maeda, Akinori, Kokichi Yamamoto, Kouhei Yamashita, et al.. (1998). The expression of co‐stimulatory molecules and their relation‐ ship to the prognosis of human acute myeloid leukaemia: poor prognosis of B7‐2‐positive leukaemia. British Journal of Haematology. 102(5). 1257–1262. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takakuni Tanizawa Breakdown of academic impact, for papers by Yutaka Furumitsu Breakdown of academic impact, for papers by Georg Stummvoll Breakdown of academic impact, for papers by Е Н Александрова Breakdown of academic impact, for papers by Markus Zeisbrich Breakdown of academic impact, for papers by Wei‐Cheng Tseng Breakdown of academic impact, for papers by Kathrin Schmidbauer Breakdown of academic impact, for papers by Christopher Collins Breakdown of academic impact, for papers by Yongen Chang Breakdown of academic impact, for papers by Zane Kaplan
Rankless by CCL
2026